CG Oncology, Inc. Common stock

CGONNASDAQHealthcare● Active

$53.64

$-0.08(-0.14%)

Market Cap$4.7B

P/E Ratio—

52W High$75.5

52W Low$23.65

Avg Volume1.2M

Open$55.06

Beta0.31

Employees Ownership Insider Trades

CG Oncology, Inc. Common stock (CGON) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · CGON · as of Feb 27, 2026

Latest filing snapshot

142

+29+25.66%vs prior year

CG Oncology, Inc. Common stock (CGON) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

142

Change (1Y)

+29

Growth % (1Y)

+25.66%

Revenue / Employee

$28.5K

Net Income / Employee

$-1.13M

Market Cap

$4.7B

CGON Employee Count

2023 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-02-27	2025-12-31	142	+29	+25.66%
2025-03-28	2024-12-31	113	+52	+85.25%
2024-03-26	2023-12-31	61	—	—

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

LEGN

Legend Biotech Corporation

2,600$5.9B #2

AAPG

Ascentage Pharma Group International

567$1.6B #3

APGE

Apogee Therapeutics, Inc.

196$5.1B #4

CGON

CG Oncology, Inc. Common stockYOU

Centessa Pharmaceuticals plc

77$6.1B

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · CGON peer comparison

About CGON employees

CGON Employees · Headcount

CG Oncology, Inc. Common stock (CGON) employee data is sourced from the annual SEC 10-K filing. As of 2025, CG Oncology, Inc. Common stock had 142 full-time employees globally. Full-time employees only. Global consolidated headcount.

CG Oncology, Inc. Common stock employs 142 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $28,451, reflecting the company's operational efficiency.

CG Oncology, Inc. Common stock's workforce increased by 29 (25.66%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

CG Oncology, Inc. Common stock's revenue per employee of $28,451 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

CGON Employees · 5 questions

As of the latest SEC 10-K filing (2025), CG Oncology, Inc. Common stock had 142 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

CG Oncology, Inc. Common stock employee counthow many employees does CG Oncology, Inc. Common stock haveCGON total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-02-27